Media Centre

Press Releases

Date Year  
2017.12.11 China Regenerative Medicine Enters into a Framework Agreement to Acquire Hua Yuan Medicine - Expands China Medical Market Sales Network
2017.12.09 Hong Kong International Regenerative Centre Holds a Seminar on “Non-invasive Cancer Therapy”
2017.11.28 CRMI attains 2018 Hong Kong's Most Valuable Companies Awards (HKMVC)
2017.11.13 Fund Invested Completes Acquisition of U.S Cosmeceuticals Brand - Obagi
2017.10.30 CRMI Entered A Strategic Agreement With Top Gene
2017.10.20 Wei Kai Bioeng Self-Developed “3D Flo Cell Culture System” Entered National Institutes of Health
2017.10.16 “Acornea” Marks A New Milestone In Ophthalmology Successfully attended ESCRS 2017
2017.09.04 CEO Mr. Chen Chunguo Holds a Meeting with Government Official of Shaanxi Xixian New Area - Discuss the Strategic Deployment of Regenerative Medicine Industry Develop Hi-tech Cosmeceuticals Industrial Park
2017.08.28 HKSAR Chief Executive Carrie Lam Cheng Yuet-ngor Visits Tianjin Binhai New Area - Receives the Management of Tianjin Weikai Bioeng Limited, a Subsidiary of China Regenerative Medicine
2017.08.14 Professor Andrey Alekseev, Chairman of Russian National Burn Association - Visits Shaanxi Aierfu ActivTissue Engineering Co., Ltd., a Subsidiary of China Regenerative Medicine
2017.08.12 R&D Team of “Acornea” Invited to Share the R&D and Application Experience of the First Chinese Bio- engineered Cornea at Oxford
2017.07.31 CRMI Established Joint Laboratory for Regenerative Medicine Technology of National Ophthalmic Engineering Center Enhancing Product Technology & Promoting Development of Ophthalmic Technology
2017.07.25 “Acornea” expands clinical applications Completed FDA registration
2017.07.19 Financial Secretary of HK SAR Paul Chan Mo-po Leads Delegation on Visit to the Group Encourages to Promote the Innovative Technology Development of Regenerative Medicine
2017.07.18 CRMI Announces Annual Result Optimize Management Mode Significant Increase in Revenue
  Fund Invested to Acquire U.S Cosmeceuticals Brand-Obagi
2017.07.05 Bio-engineered Cornea Listed as a Multicenter Research Subject for Clinical Applications of Scientific Research Plan of Blindness Prevention of National Health and Family Planning Commission of China Enhances Corneal Transplant Development & Improves the Level of Scientific Research on Clinical Application
2017.06.16 China Regenerative Medicine Pushes Forward Whole Industry Chain Deployment with the Official Inauguration of its HK International Regenerative Centre and China Stem Cell Clinical Applications Centre
2017.06.08 CRMI Entered Into enter into A Strategic Cooperation Agreement With SIMC
2017.06.06 BioCell Technology Limited attains 2017 outstanding technology award on the Nobel Laureate Series 2017 Annual Award Program Ceremony

IR Contact

China Regenerative Medicine International Limited

A:

10/F, Dah Sing Financial Center, 108 Gloucester Road, Wan chai, Hong Kong

E: info@crmi.hk|

T: +852 3966 8388 |

F: +852 2802 0026